HMGB1 antagonist treatment of severe sepsis Grant US-11883461-B2 United States of America 30 Jan 2024
HMGB1 antagonist treatment of acute lung injury Grant US-11684652-B2 United States of America 27 Jun 2023
HMGB1 antagonist treatment of severe sepsis Grant US-11524048-B2 United States of America 13 Dec 2022
HMGB1 antagonist treatment of diabetic peripheral neuropathy Grant US-11471508-B2 United States of America 18 Oct 2022
Composition for preventing or treating of sepsis comprising Hederacolchiside E Application KR-20220111520-A Republic of Korea 09 Aug 2022
HMGB1 ANTAGONIST Application WO-2020227603-A1 World Intellectual Property Organisation (WIPO) 12 Nov 2020
A composition comprising decursin derivative for preventing or treating sepsis or septic… Application KR-102109744-B1 Republic of Korea 12 May 2020
2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivatives and use thereof Grant US-9932355-B2 United States of America 03 Apr 2018
Composition for prevention or treatment of sepsis comprising flavone-type compound Application KR-20160105196-A Republic of Korea 06 Sep 2016
Pharmaceutical composition for sepsis and septic shock comprising methythiouracil Application KR-101616367-B1 Republic of Korea 28 Apr 2016